Compare Republic Services Inc. Common Stock (RSG) vs Viatris Inc (VTRS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Republic Services Inc. Common Stock vs Viatris Inc — how do they compare? Republic Services Inc. Common Stock trades at $226.87 (market cap $67.34B), while Viatris Inc trades at $17.59 (market cap $19.81B). The key difference: Republic Services Inc. Common Stock is far larger — about 3.4× Viatris Inc's market cap, and Viatris Inc pays the higher dividend (2.78%). Which is the better fit depends on your goals.
| RSG | VTRS | |
|---|---|---|
Market Cap | $67.34B | $19.81B |
Volume | 955,255 | 7,547,542 |
Sector | Industrials | Health |
52-Week High | $232.27 | $18.27 |
52-Week Low | $197.73 | $9.98 |
Enterprise Value | $81.53B | $31.92B |
Dividend Yield | 1.22% | 2.78% |
Typical Hold Time | — | 57 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Viatris (VTRS) trades at $17.44, down 0.57% on the day, with a bullish technical signal supported by moving averages. The company has beaten earnings estimates for three consecutive quarters, though it reported a net loss of $3.51B in 2025. Recent news highlights include FDA approval for WAKIX in Japan and recognition as a top employer. Analyst consensus is mixed with a $22.17 price target representing 27% upside potential.
The stock presents a value opportunity with reasonable P/S and P/B ratios, but faces fundamental challenges including negative profit margins and high debt. Positive cash flow generation and consistent earnings beats provide support, while competitive pressures and execution risks remain concerns for investors seeking turnaround potential in the healthcare sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Republic Services Inc. Common Stock
Republic Services Inc. is a waste management company that provides non-hazardous solid waste collection, transfer, disposal, and recycling services across North America.
Read more on RSG →About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →
